The global Automated And Closed Cell Therapy Processing Systems market size is predicted to grow from US$ 1362 million in 2025 to US$ 4291 million in 2031; it is expected to grow at a CAGR of 21.1% from 2025 to 2031.
Automated and closed cell therapy processing systems are specialized technologies used in the field of regenerative medicine and cell therapy. These systems refer to the use of automated technology and equipment to perform various steps involved in the manufacturing and processing of cell-based therapies. This includes processes such as cell isolation, expansion, culture, harvesting, and quality control. Automation aims to reduce variability, improve reproducibility, and enhance the efficiency of cell therapy production. By automating these processes, it becomes possible to achieve higher throughput, maintain sterility, and ensure consistency in the final product. Closed systems in cell therapy processing refer to the use of fully enclosed environments and devices that minimize the exposure of cells to the external environment throughout the manufacturing process. Closed systems are critical for maintaining the safety and quality of cell therapies by reducing the risk of microbial contamination and protecting the cells from exposure to harmful agents.
North America is the largest Automated and Closed Cell Therapy Processing Systems market, which has a share about 41%, followed by Asia-Pacific and Europe with a market share of 34% and 24%, respectively. In terms of product type, Non-Stem Cell Therapy is the largest segment, occupied for a share of 90%. And in terms of application, Industry is the largest segment, which has a share about 66%.
The 鈥淎utomated And Closed Cell Therapy Processing Systems Industry Forecast鈥� looks at past sales and reviews total world Automated And Closed Cell Therapy Processing Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Automated And Closed Cell Therapy Processing Systems sales for 2025 through 2031. With Automated And Closed Cell Therapy Processing Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated And Closed Cell Therapy Processing Systems industry.
This Insight Report provides a comprehensive analysis of the global Automated And Closed Cell Therapy Processing Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Automated And Closed Cell Therapy Processing Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Automated And Closed Cell Therapy Processing Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated And Closed Cell Therapy Processing Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated And Closed Cell Therapy Processing Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Automated And Closed Cell Therapy Processing Systems market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stem Cell Therapy
Non-Stem Cell Therapy
Segmentation by Application:
Academia
Industry
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Automated And Closed Cell Therapy Processing Systems Market Size (2020-2031)
2.1.2 Automated And Closed Cell Therapy Processing Systems Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Automated And Closed Cell Therapy Processing Systems by Country/Region (2020, 2024 & 2031)
2.2 Automated And Closed Cell Therapy Processing Systems Segment by Type
2.2.1 Stem Cell Therapy
2.2.2 Non-Stem Cell Therapy
2.3 Automated And Closed Cell Therapy Processing Systems Market Size by Type
2.3.1 Automated And Closed Cell Therapy Processing Systems Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Automated And Closed Cell Therapy Processing Systems Market Size Market Share by Type (2020-2025)
2.4 Automated And Closed Cell Therapy Processing Systems Segment by Application
2.4.1 Academia
2.4.2 Industry
2.5 Automated And Closed Cell Therapy Processing Systems Market Size by Application
2.5.1 Automated And Closed Cell Therapy Processing Systems Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Automated And Closed Cell Therapy Processing Systems Market Size Market Share by Application (2020-2025)
3 Automated And Closed Cell Therapy Processing Systems Market Size by Player
3.1 Automated And Closed Cell Therapy Processing Systems Market Size Market Share by Player
3.1.1 Global Automated And Closed Cell Therapy Processing Systems Revenue by Player (2020-2025)
3.1.2 Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Player (2020-2025)
3.2 Global Automated And Closed Cell Therapy Processing Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Automated And Closed Cell Therapy Processing Systems by Region
4.1 Automated And Closed Cell Therapy Processing Systems Market Size by Region (2020-2025)
4.2 Global Automated And Closed Cell Therapy Processing Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Automated And Closed Cell Therapy Processing Systems Market Size Growth (2020-2025)
4.4 APAC Automated And Closed Cell Therapy Processing Systems Market Size Growth (2020-2025)
4.5 Europe Automated And Closed Cell Therapy Processing Systems Market Size Growth (2020-2025)
4.6 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size Growth (2020-2025)
5 Americas
5.1 Americas Automated And Closed Cell Therapy Processing Systems Market Size by Country (2020-2025)
5.2 Americas Automated And Closed Cell Therapy Processing Systems Market Size by Type (2020-2025)
5.3 Americas Automated And Closed Cell Therapy Processing Systems Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Automated And Closed Cell Therapy Processing Systems Market Size by Region (2020-2025)
6.2 APAC Automated And Closed Cell Therapy Processing Systems Market Size by Type (2020-2025)
6.3 APAC Automated And Closed Cell Therapy Processing Systems Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2020-2025)
7.2 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Type (2020-2025)
7.3 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems by Region (2020-2025)
8.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Type (2020-2025)
8.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Automated And Closed Cell Therapy Processing Systems Market Forecast
10.1 Global Automated And Closed Cell Therapy Processing Systems Forecast by Region (2026-2031)
10.1.1 Global Automated And Closed Cell Therapy Processing Systems Forecast by Region (2026-2031)
10.1.2 Americas Automated And Closed Cell Therapy Processing Systems Forecast
10.1.3 APAC Automated And Closed Cell Therapy Processing Systems Forecast
10.1.4 Europe Automated And Closed Cell Therapy Processing Systems Forecast
10.1.5 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Forecast
10.2 Americas Automated And Closed Cell Therapy Processing Systems Forecast by Country (2026-2031)
10.2.1 United States Market Automated And Closed Cell Therapy Processing Systems Forecast
10.2.2 Canada Market Automated And Closed Cell Therapy Processing Systems Forecast
10.2.3 Mexico Market Automated And Closed Cell Therapy Processing Systems Forecast
10.2.4 Brazil Market Automated And Closed Cell Therapy Processing Systems Forecast
10.3 APAC Automated And Closed Cell Therapy Processing Systems Forecast by Region (2026-2031)
10.3.1 China Automated And Closed Cell Therapy Processing Systems Market Forecast
10.3.2 Japan Market Automated And Closed Cell Therapy Processing Systems Forecast
10.3.3 Korea Market Automated And Closed Cell Therapy Processing Systems Forecast
10.3.4 Southeast Asia Market Automated And Closed Cell Therapy Processing Systems Forecast
10.3.5 India Market Automated And Closed Cell Therapy Processing Systems Forecast
10.3.6 Australia Market Automated And Closed Cell Therapy Processing Systems Forecast
10.4 Europe Automated And Closed Cell Therapy Processing Systems Forecast by Country (2026-2031)
10.4.1 Germany Market Automated And Closed Cell Therapy Processing Systems Forecast
10.4.2 France Market Automated And Closed Cell Therapy Processing Systems Forecast
10.4.3 UK Market Automated And Closed Cell Therapy Processing Systems Forecast
10.4.4 Italy Market Automated And Closed Cell Therapy Processing Systems Forecast
10.4.5 Russia Market Automated And Closed Cell Therapy Processing Systems Forecast
10.5 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Forecast by Region (2026-2031)
10.5.1 Egypt Market Automated And Closed Cell Therapy Processing Systems Forecast
10.5.2 South Africa Market Automated And Closed Cell Therapy Processing Systems Forecast
10.5.3 Israel Market Automated And Closed Cell Therapy Processing Systems Forecast
10.5.4 Turkey Market Automated And Closed Cell Therapy Processing Systems Forecast
10.6 Global Automated And Closed Cell Therapy Processing Systems Forecast by Type (2026-2031)
10.7 Global Automated And Closed Cell Therapy Processing Systems Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Automated And Closed Cell Therapy Processing Systems Forecast
11 Key Players Analysis
11.1 Cytiva
11.1.1 Cytiva Company Information
11.1.2 Cytiva Automated And Closed Cell Therapy Processing Systems Product Offered
11.1.3 Cytiva Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Cytiva Main Business Overview
11.1.5 Cytiva Latest Developments
11.2 Miltenyi Biotec
11.2.1 Miltenyi Biotec Company Information
11.2.2 Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Product Offered
11.2.3 Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Miltenyi Biotec Main Business Overview
11.2.5 Miltenyi Biotec Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Product Offered
11.3.3 Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Terumo
11.4.1 Terumo Company Information
11.4.2 Terumo Automated And Closed Cell Therapy Processing Systems Product Offered
11.4.3 Terumo Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Terumo Main Business Overview
11.4.5 Terumo Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Automated And Closed Cell Therapy Processing Systems Product Offered
11.5.3 Merck Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Product Offered
11.6.3 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Sartorius
11.7.1 Sartorius Company Information
11.7.2 Sartorius Automated And Closed Cell Therapy Processing Systems Product Offered
11.7.3 Sartorius Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sartorius Main Business Overview
11.7.5 Sartorius Latest Developments
11.8 Lonza
11.8.1 Lonza Company Information
11.8.2 Lonza Automated And Closed Cell Therapy Processing Systems Product Offered
11.8.3 Lonza Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Lonza Main Business Overview
11.8.5 Lonza Latest Developments
11.9 Boyalife (ThermoGenesis)
11.9.1 Boyalife (ThermoGenesis) Company Information
11.9.2 Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Product Offered
11.9.3 Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Boyalife (ThermoGenesis) Main Business Overview
11.9.5 Boyalife (ThermoGenesis) Latest Developments
11.10 EurekaBio
11.10.1 EurekaBio Company Information
11.10.2 EurekaBio Automated And Closed Cell Therapy Processing Systems Product Offered
11.10.3 EurekaBio Automated And Closed Cell Therapy Processing Systems Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 EurekaBio Main Business Overview
11.10.5 EurekaBio Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
